Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
37
ROIV Quote, Financials, Valuation and Earnings
Last price:
$11.21
Seasonality move
:
5.18%
Day range:
$11.09 - $11.32
52-week range:
$8.73 - $13.06
Dividend yield:
0%
P/E ratio:
1.91x
P/S ratio:
108.75x
P/B ratio:
1.63x
Volume:
5M
Avg. volume:
5.7M
1-year change:
3.55%
Market cap:
$7.6B
Revenue:
$29.1M
EPS (TTM):
-$0.25
Roivant Sciences Number of Institutional Trades
Roivant Sciences Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$14.5B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$12.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Roivant Sciences Institutional Ownership
-
What Percentage Of ROIV Is Owned by Institutions?
-- of ROIV is owned by institutions.
-
How Many Institutions Own ROIV Shares?
Roivant Sciences stock is owned by 611 institutional shareholders at this time.
-
Have Institutions Been Buying ROIV Stock?
Yes, institutions have bought 716.1M shares of ROIV in the last quarter.
-
Have Institutions Been Selling ROIV Stock?
Yes, institutions have sold 621.3M shares of ROIV over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
